肠道微生物群和口腔扁平苔藓之间的因果关系:来自孟德尔随机化研究的见解
The Causal Relationship between Gut Microbiota and Oral Lichen Planus: Insights from Mendelian Randomization Studies
DOI: 10.12677/acm.2025.1551433, PDF,    国家自然科学基金支持
作者: 符兴国, 张海山, 李耀梅:广西医科大学口腔医学院/附属口腔医院,口腔预防科,广西 南宁;广西医科大学口腔医学院/附属口腔医院,广西卫生健康委员会口腔传染病防治重点实验室,广西 南宁;广西医科大学口腔医学院/附属口腔医院,广西口腔颌面修复重建重点实验室,广西 南宁;曾晓娟*:广西医科大学口腔医学院/附属口腔医院,口腔预防科,广西 南宁
关键词: 口腔扁平苔藓肠道菌群孟德尔随机化Oral Lichen Planus Gut Microbiota Mendelian Randomization
摘要: 背景与目的:口腔扁平苔藓(Oral lichen planus, OLP)是一种口腔黏膜慢性炎症性疾病。先前的研究表明,肠道微生物群在调节宿主免疫系统和炎症反应中具有重要作用,并与多种慢性炎症性疾病密切相关。然而,肠道菌群与OLP之间的因果关系尚未明确。本研究利用孟德尔随机化(MR)探索GM与OLP的因果关系,为潜在的发病机制和治疗策略提供新的视角。方法:本研究利用双样本(MR)方法探讨肠道菌群与OLP风险之间的潜在因果关系。肠道菌群遗传数据来源于MiBioGen联盟的全基因组关联研究(GWAS),包括18,340名欧洲血统参与者,涵盖119个属水平的菌群分类。OLP的GWAS数据来自FinnGen生物库(795例OLP患者和499,553名对照)。采用逆方差加权(IVW)、MR-Egger、加权中位数、简单模式和加权模式等多种方法,通过计算比值比(OR)和置信区间(CI)评估因果关系,并使用MR-Egger截距检验、Cochran’s Q检验和留一法分析进行敏感性分析以确保结果的稳健性。结果:IVW方法显示,Subdoligranulum (OR = 0.548, 95% CI: 0.321~0.937, p = 0.028)、Family XIII UCG001 (OR = 0.583, 95% CI: 0.346~0.982, p = 0.043)、Prevotella7 (OR = 0.766, 95% CI: 0.589~0.995, p = 0.046)和Intestinibacter (OR = 0.616, 95% CI: 0.407~0.933, p = 0.022)与OLP风险降低相关,而Ruminococcaceae UCG009 (OR = 1.459, 95% CI: 1.037~2.054, p = 0.030)与OLP风险增加相关。敏感性分析未发现显著的异质性或多效性(p > 0.05),留一法分析表明结果稳健。结论:本研究通过孟德尔随机化分析首次揭示了肠道菌群与OLP风险之间的潜在因果关系。结果表明,Subdoligranulum、Family XIII UCG001、Prevotella7和Intestinibacter可能具有保护作用,而Ruminococcaceae UCG009则与OLP风险增加相关。
Abstract: Background and Objectives: Oral lichen planus (OLP) is a chronic inflammatory disease of the oral mucosa. Previous studies have indicated that the gut microbiota plays a crucial role in regulating the host immune system and inflammatory responses, and is closely associated with various chronic inflammatory diseases. However, the causal relationship between the gut microbiota and OLP remains unclear. This study utilized Mendelian randomization (MR) to explore the causal relationship between the gut microbiota (GM) and OLP, providing new insights into potential pathogenesis and therapeutic strategies. Methods: This study employed a two-sample MR approach to investigate the potential causal relationship between the gut microbiota and OLP risk. The gut microbiota genetic data were sourced from the MiBioGen consortium’s genome-wide association study (GWAS), which included 18,340 participants of European ancestry and covered 119 genera-level microbial taxa. The GWAS data for OLP came from the FinnGen biobank (795 OLP patients and 499,553 controls). Various methods, including inverse variance weighting (IVW), MR-Egger, weighted median, simple mode, and weighted mode, were applied to estimate causal relationships by calculating odds ratios (OR) and confidence intervals (CI). Sensitivity analyses were conducted using MR-Egger intercept test, Cochran’s Q test, and leave-one-out analysis to ensure the robustness of the results. Results: The IVW method revealed that Subdoligranulum (OR = 0.548, 95% CI: 0.321~0.937, p = 0.028), Family XIII UCG001 (OR = 0.583, 95% CI: 0.346~0.982, p = 0.043), Prevotella7 (OR = 0.766, 95% CI: 0.589~0.995, p = 0.046), and Intestinibacter (OR = 0.616, 95% CI: 0.407~0.933, p = 0.022) were associated with a decreased risk of OLP, while Ruminococcaceae UCG009 (OR = 1.459, 95% CI: 1.037~2.054, p = 0.030) was associated with an increased risk of OLP. Sensitivity analysis did not reveal significant heterogeneity or pleiotropy (p > 0.05), and the leave-one-out analysis indicated robust results. Conclusion: This study, through Mendelian randomization analysis, is the first to reveal a potential causal relationship between the gut microbiota and OLP risk. The findings suggest that Subdoligranulum, Family XIII UCG001, Prevotella7, and Intestinibacter may have a protective effect, while Ruminococcaceae UCG009 is associated with an increased risk of OLP.
文章引用:符兴国, 张海山, 李耀梅, 曾晓娟. 肠道微生物群和口腔扁平苔藓之间的因果关系:来自孟德尔随机化研究的见解[J]. 临床医学进展, 2025, 15(5): 768-778. https://doi.org/10.12677/acm.2025.1551433

参考文献

[1] González‐Moles, M.Á., Warnakulasuriya, S., González‐Ruiz, I., González‐Ruiz, L., Ayén, Á., Lenouvel, D., et al. (2020) Worldwide Prevalence of Oral Lichen Planus: A Systematic Review and Meta‐Analysis. Oral Diseases, 27, 813-828. [Google Scholar] [CrossRef] [PubMed]
[2] McCartan, B.E. and Healy, C.M. (2008) The Reported Prevalence of Oral Lichen Planus: A Review and Critique. Journal of Oral Pathology & Medicine, 37, 447-453. [Google Scholar] [CrossRef] [PubMed]
[3] Cheng, L.L. (2022) The Proportion of Oral Lichen Planus Cases with Malignant Transformation May Be Higher, Than Reported to Date. Journal of Evidence-Based Dental Practice, 22, Article ID: 101717. [Google Scholar] [CrossRef] [PubMed]
[4] Warnakulasuriya, S., Kujan, O., Aguirre‐Urizar, J.M., Bagan, J.V., González‐Moles, M.Á., Kerr, A.R., et al. (2020) Oral Potentially Malignant Disorders: A Consensus Report from an International Seminar on Nomenclature and Classification, Convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases, 27, 1862-1880. [Google Scholar] [CrossRef] [PubMed]
[5] Nammour, S., El Mobadder, M., Brugnera, A.J., Namour, M., Houeis, S., Heysselaer, D., et al. (2021) Photobiomodulation Therapy vs. Corticosteroid for the Management of Erosive/Ulcerative and Painful Oral Lichen Planus. Assessment of Success Rate during One-Year Follow-Up: A Retrospective Study. Healthcare, 9, Article 1137. [Google Scholar] [CrossRef] [PubMed]
[6] Mozaffari, H.R., Zavattaro, E., Saeedi, M., Lopez-Jornet, P., Sadeghi, M., Safaei, M., et al. (2019) Serum and Salivary Interleukin-4 Levels in Patients with Oral Lichen Planus: A Systematic Review and Meta-Analysis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 128, 123-131. [Google Scholar] [CrossRef] [PubMed]
[7] Pouralibaba, F., Babaloo, Z., Pakdel, F., et al. (2013) Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus. Journal of Dental Research, Dental Clinics, Dental Prospects, 7, 91-94.
[8] Wang, K., Miao, T., Lu, W., He, J., Cui, B., Li, J., et al. (2015) Analysis of Oral Microbial Community and Th17‐associated Cytokines in Saliva of Patients with Oral Lichen Planus. Microbiology and Immunology, 59, 105-113. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, J., Liu, K., Sun, X., Shi, X., Zhao, G. and Yang, Z. (2022) Microbiome Landscape of Lesions and Adjacent Normal Mucosal Areas in Oral Lichen Planus Patient. Frontiers in Microbiology, 13, Article 992065. [Google Scholar] [CrossRef] [PubMed]
[10] Pignatelli, P., Curia, M.C., Tenore, G., Bondi, D., Piattelli, A. and Romeo, U. (2024) Oral Bacteriome and Oral Potentially Malignant Disorders: A Systematic Review of the Associations. Archives of Oral Biology, 160, Article ID: 105891. [Google Scholar] [CrossRef] [PubMed]
[11] Shi, X., Ma, T., Sakandar, H.A., Menghe, B. and Sun, Z. (2022) Gut Microbiome and Aging Nexus and Underlying Mechanism. Applied Microbiology and Biotechnology, 106, 5349-5358. [Google Scholar] [CrossRef] [PubMed]
[12] Lezutekong, J.N., Nikhanj, A. and Oudit, G.Y. (2018) Imbalance of Gut Microbiome and Intestinal Epithelial Barrier Dysfunction in Cardiovascular Disease. Clinical Science, 132, 901-904. [Google Scholar] [CrossRef] [PubMed]
[13] Jandhyala, S.M. (2015) Role of the Normal Gut Microbiota. World Journal of Gastroenterology, 21, 8787-8803. [Google Scholar] [CrossRef] [PubMed]
[14] Hotamisligil, G.S. (2017) Inflammation, Metaflammation and Immunometabolic Disorders. Nature, 542, 177-185. [Google Scholar] [CrossRef] [PubMed]
[15] Santos, W.S., Solon, I.G. and Branco, L.G.S. (2024) Impact of Periodontal Lipopolysaccharides on Systemic Health: Mechanisms, Clinical Implications, and Future Directions. Molecular Oral Microbiology, 40, 117-127. [Google Scholar] [CrossRef] [PubMed]
[16] Narayanan, A., Kieri, O., Vesterbacka, J., Manoharan, L., Chen, P., Ghorbani, M., et al. (2024) Exploring the Interplay between Antiretroviral Therapy and the Gut-Oral Microbiome Axis in People Living with HIV. Scientific Reports, 14, Article No. 17820. [Google Scholar] [CrossRef] [PubMed]
[17] Maki, K.A., Kazmi, N., Barb, J.J. and Ames, N. (2020) The Oral and Gut Bacterial Microbiomes: Similarities, Differences, and Connections. Biological Research for Nursing, 23, 7-20. [Google Scholar] [CrossRef] [PubMed]
[18] Chen, B., Lin, W., Li, Y., Bi, C., Du, L., Liu, Y., et al. (2023) Roles of Oral Microbiota and Oral-Gut Microbial Transmission in Hypertension. Journal of Advanced Research, 43, 147-161. [Google Scholar] [CrossRef] [PubMed]
[19] Buhaș, M.C., Gavrilaș, L.I., Candrea, R., Cătinean, A., Mocan, A., Miere, D., et al. (2022) Gut Microbiota in Psoriasis. Nutrients, 14, Article 2970. [Google Scholar] [CrossRef] [PubMed]
[20] Franzosa, E.A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H.J., Reinker, S., et al. (2018) Gut Microbiome Structure and Metabolic Activity in Inflammatory Bowel Disease. Nature Microbiology, 4, 293-305. [Google Scholar] [CrossRef] [PubMed]
[21] Xu, J., Zhang, S., Tian, Y., Si, H., Zeng, Y., Wu, Y., et al. (2022) Genetic Causal Association between Iron Status and Osteoarthritis: A Two-Sample Mendelian Randomization. Nutrients, 14, Article 3683. [Google Scholar] [CrossRef] [PubMed]
[22] Davies, N.M., Holmes, M.V. and Davey Smith, G. (2018) Reading Mendelian Randomisation Studies: A Guide, Glossary, and Checklist for Clinicians. BMJ, 362, k601. [Google Scholar] [CrossRef] [PubMed]
[23] Sekula, P., Del Greco M, F., Pattaro, C. and Köttgen, A. (2016) Mendelian Randomization as an Approach to Assess Causality Using Observational Data. Journal of the American Society of Nephrology, 27, 3253-3265. [Google Scholar] [CrossRef] [PubMed]
[24] Kurilshikov, A., Medina-Gomez, C., Bacigalupe, R., Radjabzadeh, D., Wang, J., Demirkan, A., et al. (2021) Large-Scale Association Analyses Identify Host Factors Influencing Human Gut Microbiome Composition. Nature Genetics, 53, 156-165. [Google Scholar] [CrossRef] [PubMed]
[25] Kurki, M.I., Karjalainen, J., Palta, P., Sipilä, T.P., Kristiansson, K., Donner, K.M., et al. (2023) FinnGen Provides Genetic Insights from a Well-Phenotyped Isolated Population. Nature, 613, 508-518. [Google Scholar] [CrossRef] [PubMed]
[26] Burgess, S., Davey Smith, G., Davies, N.M., Dudbridge, F., Gill, D., Glymour, M.M., et al. (2019) Guidelines for Performing Mendelian Randomization Investigations: Update for Summer 2023. Wellcome Open Research, 4, Article 186. [Google Scholar] [CrossRef
[27] Holmes, M.V., Ala-Korpela, M. and Smith, G.D. (2017) Mendelian Randomization in Cardiometabolic Disease: Challenges in Evaluating Causality. Nature Reviews Cardiology, 14, 577-590. [Google Scholar] [CrossRef] [PubMed]
[28] Ismail, S.B., Kumar, S.K.S. and Zain, R.B. (2007) Oral Lichen Planus and Lichenoid Reactions: Etiopathogenesis, Diagnosis, Management and Malignant Transformation. Journal of Oral Science, 49, 89-106. [Google Scholar] [CrossRef] [PubMed]
[29] Kato, L.M., Kawamoto, S., Maruya, M. and Fagarasan, S. (2014) The Role of the Adaptive Immune System in Regulation of Gut Microbiota. Immunological Reviews, 260, 67-75. [Google Scholar] [CrossRef] [PubMed]
[30] Caesar, R. (2024) The Impact of Novel Probiotics Isolated from the Human Gut on the Gut Microbiota and Health. Diabetes, Obesity and Metabolism, 27, 3-14. [Google Scholar] [CrossRef] [PubMed]
[31] Yi, C., Huang, S., Zhang, W., Guo, L., Xia, T., Huang, F., et al. (2025) Synergistic Interactions between Gut Microbiota and Short Chain Fatty Acids: Pioneering Therapeutic Frontiers in Chronic Disease Management. Microbial Pathogenesis, 199, Article ID: 107231. [Google Scholar] [CrossRef] [PubMed]
[32] Holmstrøm, K., Collins, M.D., Møller, T., Falsen, E. and Lawson, P.A. (2004) Subdoligranulum variabile gen. nov., sp. nov. from human feces. Anaerobe, 10, 197-203. [Google Scholar] [CrossRef] [PubMed]
[33] Sun, B., Jia, Y., Hong, J., Sun, Q., Gao, S., Hu, Y., et al. (2018) Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation. Journal of Agricultural and Food Chemistry, 66, 7633-7642. [Google Scholar] [CrossRef] [PubMed]
[34] Ye, J., Lv, L., Wu, W., Li, Y., Shi, D., Fang, D., et al. (2018) Butyrate Protects Mice against Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels. Frontiers in Microbiology, 9, Article 1967. [Google Scholar] [CrossRef] [PubMed]
[35] Amiri, P., Arefhosseini, S., Bakhshimoghaddam, F., Jamshidi Gurvan, H. and Hosseini, S.A. (2022) Mechanistic Insights into the Pleiotropic Effects of Butyrate as a Potential Therapeutic Agent on NAFLD Management: A Systematic Review. Frontiers in Nutrition, 9, Article 1037696. [Google Scholar] [CrossRef] [PubMed]
[36] Baumann, A., Jin, C., Brandt, A., Sellmann, C., Nier, A., Burkard, M., et al. (2020) Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. Nutrients, 12, Article 951. [Google Scholar] [CrossRef] [PubMed]
[37] Yang, T., Yang, H., Heng, C., Wang, H., Chen, S., Hu, Y., et al. (2020) Amelioration of Non-Alcoholic Fatty Liver Disease by Sodium Butyrate Is Linked to the Modulation of Intestinal Tight Junctions in Db/Db Mice. Food & Function, 11, 10675-10689. [Google Scholar] [CrossRef] [PubMed]
[38] Zhou, D., Pan, Q., Xin, F., Zhang, R., He, C., Chen, G., et al. (2017) Sodium Butyrate Attenuates High-Fat Diet-Induced Steatohepatitis in Mice by Improving Gut Microbiota and Gastrointestinal Barrier. World Journal of Gastroenterology, 23, 60-75. [Google Scholar] [CrossRef] [PubMed]
[39] Peng, L., Li, Z., Green, R.S., Holzmanr, I.R. and Lin, J. (2009) Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers. The Journal of Nutrition, 139, 1619-1625. [Google Scholar] [CrossRef] [PubMed]
[40] Zhong, S., Yang, Y., Huo, J., Sun, Y., Zhao, H., Dong, X., et al. (2025) Cyanidin-3-Rutinoside from Mori Fructus Ameliorates Dyslipidemia via Modulating Gut Microbiota and Lipid Metabolism Pathway. The Journal of Nutritional Biochemistry, 137, Article ID: 109834. [Google Scholar] [CrossRef] [PubMed]
[41] Xu, H., Huang, H., Liu, Y., Zhu, J., Zhou, Y., Chen, H., et al. (2021) Selection Strategy of Dextran Sulfate Sodium-Induced Acute or Chronic Colitis Mouse Models Based on Gut Microbial Profile. BMC Microbiology, 21, Article No. 279. [Google Scholar] [CrossRef] [PubMed]
[42] Ma, D., Zhang, M. and Feng, J. (2024) Gut Microbiota Alleviates Intestinal Injury Induced by Extended Exposure to Light via Inhibiting the Activation of NLRP3 Inflammasome in Broiler Chickens. International Journal of Molecular Sciences, 25, Article 6695. [Google Scholar] [CrossRef] [PubMed]
[43] Yeoh, Y.K., Sun, Y., Ip, L.Y.T., Wang, L., Chan, F.K.L., Miao, Y., et al. (2022) Prevotella Species in the Human Gut Is Primarily Comprised of Prevotella copri, Prevotella stercorea and Related Lineages. Scientific Reports, 12, Article No. 9055. [Google Scholar] [CrossRef] [PubMed]
[44] Patrone, V., Puglisi, E., Cardinali, M., Schnitzler, T.S., Svegliati, S., Festa, A., et al. (2017) Gut Microbiota Profile in Systemic Sclerosis Patients with and without Clinical Evidence of Gastrointestinal Involvement. Scientific Reports, 7, Article No. 14874. [Google Scholar] [CrossRef] [PubMed]
[45] Low, A.H.L., Teng, G.G., Pettersson, S., de Sessions, P.F., Ho, E.X.P., Fan, Q., et al. (2019) A Double-Blind Randomized Placebo-Controlled Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease. Seminars in Arthritis and Rheumatism, 49, 411-419. [Google Scholar] [CrossRef] [PubMed]
[46] Ao, X. and Zhang, Z. (2024) Effect of Xylo-Oligosaccharides on Intestinal Bacterial Diversity in Mice with Spleen Deficiency Constipation. Frontiers in Microbiology, 15, Article 1474374. [Google Scholar] [CrossRef] [PubMed]
[47] Li, R., Shokri, F., Rincon, A., Rivadeneira, F., Medina-Gomez, C. and Ahmadizar, F. (2023) Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes, 14, Article 1572. [Google Scholar] [CrossRef] [PubMed]
[48] Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. (2004) The Gut Microbiota as an Environmental Factor That Regulates Fat Storage. Proceedings of the National Academy of Sciences of the United States of America, 101, 15718-15723. [Google Scholar] [CrossRef] [PubMed]
[49] Wang, K., Jin, X., Li, Q., Sawaya, A.C.H.F., Le Leu, R.K., Conlon, M.A., et al. (2018) Propolis from Different Geographic Origins Decreases Intestinal Inflammation and Bacteroides Spp. Populations in a Model of DSS‐Induced Colitis. Molecular Nutrition & Food Research, 62, Article ID: 1800080. [Google Scholar] [CrossRef] [PubMed]